Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer

ACS Applied Materials and Interfaces

Volumn 7, Issue 12, 2015, Pages 6661-6673

  Yang, Qingqing ^a   Yang, Yang ^a   Li, Lian ^a   Sun, Wei ^a   Zhu, Xi ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

combination therapy; G3 C12; HPMA copolymer; prostate cancer; synergistic genotoxicity

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; DRUG INTERACTIONS; MAMMALS; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; TUMORS; UROLOGY;

COMBINATION THERAPY; G3-C12; GENOTOXICITIES; HPMA COPOLYMERS; PROSTATE CANCERS;

TARGETED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; FLUOROURACIL; HYDROXYPROPYL METHACRYLATE; METHACRYLIC ACID DERIVATIVE; NANOMATERIAL;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; HUMAN; MALE; MOUSE; NANOMEDICINE; PROCEDURES; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; FLUOROURACIL; HUMANS; MALE; METHACRYLATES; MICE; NANOMEDICINE; NANOSTRUCTURES; PROSTATIC NEOPLASMS;

EID: 84926370290     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am509204u     Document Type: Article

References (54)

1. Ascierto, P. A.; Marincola, F. M. Combination Therapy: The Next Opportunity and Challenge of Medicine J. Transl. Med. 2011, 9, 115
2. Mehta, R. S.; Barlow, W. E.; Albain, K. S.; Vandenberg, T. A.; Dakhil, S. R.; Tirumali, N. R.; Lew, D. L.; Hayes, D. F.; Gralow, J. R.; Livingston, R. B.; Hortobagyi, G. N. Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer N. Engl. J. Med. 2012, 367, 435-444
3. Joensuu, H.; Holli, K.; Heikkinen, M.; Suonio, E.; Aro, A. R.; Hietanen, P.; Huovinen, R. Combination Chemotherapy versus Single-Agent Therapy as First- and Second-Line Treatment in Metastatic Breast Cancer: a Prospective Randomized Trial J. Clin. Oncol. 1998, 16, 3720-3730
4. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
5. Zhang, Y. F.; Wang, J. C.; Bian, D. Y.; Zhang, X.; Zhang, Q. Targeted Delivery of RGD-Modified Liposomes Encapsulating both Combretastatin A-4 and Doxorubicin for Tumor Therapy: In Vitro and in Vivo Studies Eur. J. Pharm. Biopharm. 2010, 74, 467-473
6. Wang, H.; Zhao, Y.; Wu, Y.; Hu, Y. L.; Nan, K.; Nie, G.; Chen, H. Enhanced Anti-Tumor Efficacy by Co-Delivery of Doxorubicin and Paclitaxel with Amphiphilic Methoxy PEG-PLGA Copolymer Nanoparticles Biomaterials 2011, 32, 8281-8290
7. Duan, X.; Xiao, J.; Yin, Q.; Zhang, Z.; Yu, H.; Mao, S.; Li, Y. Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram ACS Nano 2013, 7, 5858-5869
8. Li, Z.-Y.; Liu, Y.; Wang, X.-Q.; Liu, L.-H.; Hu, J.-J.; Luo, G.-F.; Chen, W.-H.; Rong, L.; Zhang, X.-Z. One-Pot Construction of Functional Mesoporous Silica Nanoparticles for the Tumor-Acidity-Activated Synergistic Chemotherapy of Glioblastoma ACS Appl. Mater. Interfaces 2013, 5, 7995-8001
9. Wang, H.; Li, F.; Du, C.; Wang, H.; Mahato, R. I.; Huang, Y. Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer Mol. Pharmaceutics 2014, 11, 2600-2611
10. Ulbrich, K.; Šubr, V. Structural and Chemical Aspects of HPMA Copolymers as Drug Carriers Adv. Drug Delivery Rev. 2010, 62, 150-166
11. Larson, N.; Ghandehari, H. Polymeric Conjugates for Drug Delivery Chem. Mater. 2012, 24, 840-853
12. Yang, J.; Kopeček, J. Macromolecular Therapeutics J. Controlled Release 2014, 190, 288-303
13. Kopeček, J. Polymer-Drug Conjugates: Origins, Progress to Date and Future Directions Adv. Drug Delivery Rev. 2013, 65, 49-59
14. Krakovicova, H.; Etrych, T.; Ulbrich, K. HPMA-Based Polymer Conjugates with Drug Combination Eur. J. Pharm. Sci. 2009, 37, 405-412
15. Kostková, H.; Etrych, T.; Říhová, B.; Ulbrich, K. Synergistic Effect of HPMA Copolymer-Bound Doxorubicin and Dexamethasone in Vivo on Mouse Lymphomas J. Bioact. Compat. Polym. 2011, 26, 270-286
16. Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P. E.; Hennink, W. E.; Storm, G. Simultaneous Delivery of Doxorubicin and Gemcitabine to Tumors in Vivo Using Prototypic Polymeric Drug Carriers Biomaterials 2009, 30, 3466-3475
17. Zhou, Y.; Yang, J.; Rhim, J. S.; Kopeček, J. HPMA Copolymer-Based Combination Therapy Toxic to Both Prostate Cancer Stem/Progenitor Cells and Differentiated Cells Induces Durable Anti-Tumor Effects J. Controlled Release 2013, 172, 946-953
18. Kostkova, H.; Etrych, T.; Rihova, B.; Kostka, L.; Starovoytova, L.; Kovar, M.; Ulbrich, K. HPMA Copolymer Conjugates of DOX and Mitomycin C for Combination Therapy: Physicochemical Characterization, Cytotoxic Effects, Combination Index Analysis, and Anti-Tumor Efficacy Macromol. Biosci. 2013, 13, 1648-1660
19. Karhadkar, S. S.; Bova, G. S.; Abdallah, N.; Dhara, S.; Gardner, D.; Maitra, A.; Isaacs, J. T.; Berman, D. M.; Beachy, P. A. Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis Nature 2004, 431, 707-712
20. Greco, F.; Vicent, M. J. Combination Therapy: Opportunities and Challenges for Polymer-Drug Conjugates as Anticancer Nanomedicines Adv. Drug Delivery Rev. 2009, 61, 1203-1213
21. Lammers, T. Improving the Efficacy of Combined Modality Anticancer Therapy Using HPMA Copolymer-Based Nanomedicine Formulations Adv. Drug Delivery Rev. 2010, 62, 203-230
22. Kopeček, J.; Kopečková, P. HPMA Copolymers: Origins, Early Developments, Present, and Future Adv. Drug Delivery Rev. 2010, 62, 122-149
23. Lammers, T.; Subr, V.; Ulbrich, K.; Hennink, W. E.; Storm, G.; Kiessling, F. Polymeric Nanomedicines for Image-Guided Drug Delivery and Tumor-Targeted Combination Therapy Nano Today 2010, 5, 197-212
24. Pike, D. B.; Ghandehari, H. HPMA Copolymer-Cyclic RGD Conjugates for Tumor Targeting Adv. Drug Delivery Rev. 2010, 62, 167-183
25. Boscher, C.; Dennis, J. W.; Nabi, I. R. Glycosylation, Galectins, and Cellular Signaling Curr. Opin. Cell Biol. 2011, 23, 383-392
26. Yang, Y.; Zhou, Z.; He, S.; Fan, T.; Jin, Y.; Zhu, X.; Chen, C.; Zhang, Z.-r.; Huang, Y. Treatment of Prostate Carcinoma with (Galectin-3)-Targeted HPMA Copolymer-(G3-C12)-5-Fluorouracil Conjugates Biomaterials 2012, 33, 2260-2271
27. Yang, Y.; Li, L.; Zhou, Z.; Yang, Q.; Liu, C.; Huang, Y. Targeting Prostate Carcinoma by G3-C12 Peptide Conjugated N -(2-Hydroxypropyl)methacrylamide Copolymers Mol. Pharmaceutics 2014, 11, 3251-3260
28. Binaschi, M.; Zunino, F.; Capranico, G. Mechanism of Action of DNA Topoisomerase Inhibitors Stem Cells 1995, 13, 369-379
29. Vincent, J.; Mignot, G.; Chalmin, F.; Ladoire, S.; Bruchard, M.; Chevriaux, A.; Martin, F.; Apetoh, L.; Rebe, C.; Ghiringhelli, F. 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity Cancer Res. 2010, 70, 3052-3061
30. Jassem, J.; Pienkowski, T.; Pluzanska, A.; Jelic, S.; Gorbunova, V.; Mrsic-Krmpotic, Z.; Berzins, J.; Nagykalnai, T.; Wigler, N.; Renard, J.; Munier, S.; Weil, C.; Central and Eastern Europe and Israel Pacitaxel Breast Cancer Study Group Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women with Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial J. Clin. Oncol. 2001, 19, 1707-1715
31. Smith, F. P.; Hoth, D. F.; Levin, B.; Karlin, D. A.; MacDonald, J. S.; Woolley, P. V., III; Schein, P. S. 5-Fluorouracil, Adriamycin, and Mitomycin-C (FAM) Chemotherapy for Advanced Adenocarcinoma of the Pancreas Cancer 1980, 46, 2014-2018
32. Ding, X.; Liu, Y.; Li, J.; Luo, Z.; Hu, Y.; Zhang, B.; Liu, J.; Zhou, J.; Cai, K. Hydrazone-Bearing PMMA-Functionalized Magnetic Nanocubes as pH-Responsive Drug Carriers for Remotely Targeted Cancer Therapy in Vitro and in Vivo ACS Appl. Mater. Interfaces 2014, 6, 7395-7407
33. Ulbrich, K.; Subr, V.; Strohalm, J.; Plocova, D.; Jelinkova, M.; Rihova, B. Polymeric Drugs Based on Conjugates of Synthetic and Natural Macromolecules. I. Synthesis and Physico-Chemical Characterisation J. Controlled Release 2000, 64, 63-79
34. Etrych, T.; Mrkvan, T.; Chytil, P.; Koňák, Č.; Říhová, B.; Ulbrich, K. N -(2-Hydroxypropyl) Methacrylamide-Based Polymer Conjugates with pH-Controlled Activation of Doxorubicin. I. New Synthesis, Physicochemical Characterization and Preliminary Biological Evaluation J. Appl. Polym. Sci. 2008, 109, 3050-3061
35. Rejmanová, P.; Labský, J.; Kopeček, J. Aminolyses of Monomeric and Polymeric 4-Nitrophenyl Esters of N -Methacryloylamino Acids Macromol. Chem. Phys. 1977, 178, 2159-2168
36. Yuan, F.; Chen, F.; Xiang, Q. Y.; Qin, X.; Zhang, Z. R.; Huang, Y. Synthesis and Characterization of HPMA Copolymer-5-FU Conjugates Chin. Chem. Lett. 2008, 19, 137-140
37. Rathi, R. C.; Kopečková, P.; Říhová, B.; Kopeček, J. N -(2-hydroxypropyl) Methacrylamide Copolymers Containing Pendant Saccharide Moieties: Synthesis and Bioadhesive Properties J. Polym. Sci., Part A: Polym. Chem. 1991, 29, 1895-1902
38. Yuan, F.; Qin, X.; Zhou, D.; Xiang, Q. Y.; Wang, M. T.; Zhang, Z. R.; Huang, Y. In Vitro Cytotoxicity, in Vivo Biodistribution and Antitumor Activity of HPMA Copolymer-5-Fluorouracil Conjugates Eur. J. Pharm. Biopharm. 2008, 70, 770-776
39. Etrych, T.; Jelínková, M.; Říhová, B.; Ulbrich, K. New HPMA Copolymers Containing Doxorubicin Bound via pH-Sensitive Linkage: Synthesis and Preliminary in Vitro and in Vivo Biological Properties J. Controlled Release 2001, 73, 89-102
40. Zhang, R.; Luo, K.; Yang, J.; Sima, M.; Sun, Y.; Janát-Amsbury, M. M.; Kopeček, J. Synthesis and Evaluation of a Backbone Biodegradable Multiblock HPMA Copolymer Nanocarrier for the Systemic Delivery of Paclitaxel J. Controlled Release 2013, 166, 66-74
41. Etrych, T.; Strohalm, J.; Chytil, P.; Černoch, P.; Starovoytova, L.; Pechar, M.; Ulbrich, K. Biodegradable Star HPMA Polymer Conjugates of Doxorubicin for Passive Tumor Targeting Eur. J. Pharm. Sci. 2011, 42, 527-539
42. Du, J. Z.; Du, X. J.; Mao, C. Q.; Wang, J. Tailor-Made Dual pH-Sensitive Polymer-Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery J. Am. Chem. Soc. 2011, 133, 17560-17563
43. Zhang, C.; Pan, D.; Luo, K.; She, W.; Guo, C.; Yang, Y.; Gu, Z. Peptide Dendrimer-Doxorubicin Conjugate-Based Nanoparticles as an Enzyme-Responsive Drug Delivery System for Cancer Therapy Adv. Healthcare Mater. 2014, 3, 1299-1308
44. Chou, T. C. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method Cancer Res. 2010, 70, 440-446
45. Wang, X.; Zhen, X.; Wang, J.; Zhang, J.; Wu, W.; Jiang, X. Doxorubicin Delivery to 3D Multicellular Spheroids and Tumors Based on Boronic Acid-Rich Chitosan Nanoparticles Biomaterials 2013, 34, 4667-4679
46. Helleday, T.; Petermann, E.; Lundin, C.; Hodgson, B.; Sharma, R. A. DNA Repair Pathways as Targets for Cancer Therapy Nat. Rev. Cancer 2008, 8, 193-204
47. Ishikawa, K.; Ishii, H.; Saito, T. DNA Damage-Dependent Cell Cycle Checkpoints and Genomic Stability DNA Cell Biol. 2006, 25, 406-411
48. Fulda, S. Targeting Apoptosis for Anticancer Therapy Semin. Cancer Biol. 2015, 31, 84-88
49. McIlroy, D.; Sakahira, H.; Talanian, R. V.; Nagata, S. Involvement of Caspase 3-Activated DNase in Internucleosomal DNA Cleavage Induced by Diverse Apoptotic Stimuli Oncogene 1999, 18, 4401-4408
50. AshaRani, P. V.; Low Kah Mun, G.; Hande, M. P.; Valiyaveettil, S. Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells ACS Nano 2009, 3, 279-290
51. Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress J. Controlled Release 2012, 161, 175-187
52. Lv, S.; Tang, Z.; Li, M.; Lin, J.; Song, W.; Liu, H.; Huang, Y.; Zhang, Y.; Chen, X. Co-Delivery of Doxorubicin and Paclitaxel by PEG-Polypeptide Nanovehicle for the Treatment of Non-Small Cell Lung Cancer Biomaterials 2014, 35, 6118-6129
53. Olson, R. D.; Mushlin, P. S.; Brenner, D. E.; Fleischer, S.; Cusack, B. J.; Chang, B. K.; Boucek, R. J., Jr. Doxorubicin Cardiotoxicity May be Caused by Its Metabolite, Doxorubicinol Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 3585-3589
54. Cortesi, E.; Aschelter, A. M.; Gioacchini, N.; Pellegrini, A.; Frati, L.; Ficorella, C.; Mazzei, N.; Marchetti, P. Efficacy and Toxicity of 5-Fluorouracil and Folates in Advanced Colon Cancer J. Chemother. 1990, 2, 47-50